ACTIVE_NOT_RECRUITING

A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is evaluating the impact a collaborative palliative care and oncology team will have on end-of-life outcomes, quality of end-of-life care, and the quality of life, symptoms, and mood of patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) receiving non-intensive therapy

Official Title

Randomized Trial of a Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy

Quick Facts

Study Start:2017-10-31
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:ACTIVE_NOT_RECRUITING

Study ID

NCT03310918

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients with AML receiving non-intensive therapy including hypomethylating agents, single-agent chemotherapy, targeted therapy agents, or single or combination non-intensive agents offered on a clinical trial, including the following populations:
  2. * Newly diagnosed AML
  3. * Relapsed AML
  4. * Primary refractory AML
  5. * The ability to provide informed consent
  6. * The ability to comprehend English or complete questionnaires with minimal assistance of an interpreter
  1. * Patients not receiving care at MGH
  2. * Patients receiving intensive chemotherapy (requiring 4-6 week hospitalization)
  3. * Patients receiving supportive care alone
  4. * Major psychiatric illness or co-morbid conditions prohibiting compliance with study procedures
  5. * Patients already receiving palliative care

Contacts and Locations

Principal Investigator

Areej El-Jawahri, MD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02114
United States
Ohio State University
Columbus, Ohio, 43210
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Areej El-Jawahri, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-10-31
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2017-10-31
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • AML
  • MDS
  • Palliative care

Additional Relevant MeSH Terms

  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes